Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience

被引:7
|
作者
Matassini, M. V. [1 ]
Marini, M. [1 ]
Angelozzi, A. [2 ]
Angelini, L. [1 ]
Shkoza, M. [1 ]
Compagnucci, P. [3 ,4 ,5 ]
Falanga, U. [3 ,4 ,5 ]
Battistoni, I. [1 ]
Pongetti, G. [1 ]
Francioni, M. [1 ]
Piva, T. [6 ]
Mucaj, A. [6 ]
Nicolini, E. [6 ]
Maolo, A. [6 ]
Di Eusanio, M. [7 ]
Munch, C. [8 ]
Dello Russo, A. [3 ,4 ,5 ]
Perna, G. [1 ]
机构
[1] Osped Riuniti Ancona, Cardiovasc Dept, Cardiol Div, Cardiac Intens Care Unit, Ancona, Italy
[2] G Mazzini Hosp, Cardiovasc Dept, Unit Cardiol & Cardiac Intens Therapy, Teramo, Italy
[3] Univ Hosp Osped Riuniti Ancona, Dept Biomed Sci & Publ Hlth, Ancona, Italy
[4] Univ Hosp Osped Riuniti Ancona, Cardiol & Arrhythmol Clin, Ancona, Italy
[5] Marche Polytech Univ, Ancona, Italy
[6] Osped Riuniti Ancona, Cardiovasc Dept, Intervent Cardiol Cardiol Div, Ancona, Italy
[7] Osped Riuniti Ancona, Cardiovasc Dept, Cardiac Surg Unit, Ancona, Italy
[8] Osped Riuniti Ancona, Anaesthesia & Cardiac Surg Intens Care, Ancona, Italy
来源
关键词
heart failure; Impella; weaning; outcomes; complications; cardiogenic shock; MECHANICAL CIRCULATORY SUPPORT; VENTRICULAR SUPPORT; DEVICE; PUMP;
D O I
10.3389/fcvm.2023.1171956
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionCardiogenic shock (CS) is a severe syndrome with poor prognosis. Short-term mechanical circulatory support with Impella devices has emerged as an increasingly therapeutic option, unloading the failing left ventricle (LV) and improving hemodynamic status of affected patients. Impella devices should be used for the shortest time necessary to allow LV recovery because of time-dependent device-related adverse events. The weaning from Impella, however, is mostly performed in the absence of established guidelines, mainly based on the experience of the individual centres. MethodsThe aim of this single center study was to retrospectively evaluate whether a multiparametrical assessment before and during Impella weaning could predict successful weaning. The primary study outcome was death occurring during Impella weaning and secondary endpoints included assessment of in-hospital outcomes. ResultsOf a total of 45 patients (median age, 60 [51-66] years, 73% male) treated with an Impella device, 37 patients underwent impella weaning/removal and 9 patients (20%) died after the weaning. Non-survivors patients after impella weaning more commonly had a previous history of known heart failure (p = 0.054) and an implanted ICD-CRT (p = 0.01), and were more frequently treated with continuous renal replacement therapy (p = 0.02). In univariable logistic regression analysis, lactates variation (%) during the first 12-24 h of weaning, lactate value after 24 h of weaning, left ventricular ejection fraction (LVEF) at the beginning of weaning, and inotropic score after 24 h from weaning beginning were associated with death. Stepwise multivariable logistic regression identified LVEF at the beginning of weaning and lactates variation (%) in the first 12-24 h from weaning beginning as the most accurate predictors of death after weaning. The ROC analysis indicated 80% accuracy (95% confidence interval = 64%-96%) using the two variables in combination to predict death after weaning from Impella. ConclusionsThis single-center experience on Impella weaning in CS showed that two easily accessible parameters as LVEF at the beginning of weaning and lactates variation (%) in the first 12-24 h from weaning begin were the most accurate predictors of death after weaning.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Outcomes of Impella 5.0 and 5.5 for cardiogenic shock: A single-center 137 patient experience
    Hong, Yeahwa
    Agrawal, Nishant
    Hess, Nicholas R.
    Ziegler, Luke A.
    Sicke, McKenzie M.
    Hickey, Gavin W.
    Ramanan, Raj
    Fowler, Jeffrey A.
    Chu, Danny
    Yoon, Pyongsoo D.
    Bonatti, Johannes O.
    Kaczorowski, David J.
    ARTIFICIAL ORGANS, 2024, 48 (07) : 771 - 780
  • [2] CLINICAL PREDICTORS OF SUCCESSFUL WEANING FROM IMPELLA SUPPORT IN CARDIOGENIC SHOCK
    Tehrani, Behnam
    Rosner, Carolyn
    Damluji, Abdulla
    Sherwood, Matthew William
    Truesdell, Alexander George
    Epps, Kelly
    Sinha, Shashank S.
    Psotka, Mitchell
    Cooper, Lauren
    Howard, Edward
    Singh, Ramesh
    Geloo, Nadim
    Barnett, Scott
    Yazdani, Shahram
    Raja, Anika
    DeFilippi, Christopher R.
    Murphy, Charles
    Desai, Shashank
    O'Connor, Christopher
    Batchelor, Wayne B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1227 - 1227
  • [3] Outcomes Of Refractory Cardiogenic Shock Patients Supported By Impella 5.5: Single Center Experience
    Cunningham, Luke C.
    El Banayosy, Ahmed M.
    Vanhooser, David W.
    Bell, Marshall T.
    Mihu, Mircea R.
    Horstmanshof, Douglas A.
    El Banayosy, Aly
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 582 - 583
  • [4] Impella 5.0 is associated with a reduction in vasoactive support and improves hemodynamics in cardiogenic shock: A single-center experience
    Bashline, Michael J.
    Rhinehart, Zachary
    Kola, Olivia
    Fowler, Jeffrey
    Kaczorowski, David
    Hickey, Gavin
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2022, 45 (05): : 462 - 469
  • [5] Impella support for cardiogenic shock and high-risk percutaneous coronary intervention: A single-center experience
    Brandao, Mariana
    Caeiro, Daniel
    Pires-Morais, Gustavo
    Almeida, Joao Goncalves
    Teixeira, Pedro Goncalves
    Silva, Marisa Passos
    Ponte, Marta
    Dias, Adelaide
    Oliveira, Marco
    Rodrigues, Alberto
    Braga, Pedro
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2021, 40 (11) : 853 - 861
  • [6] Treating Refractory Cardiogenic Shock With the TandemHeart and Impella Devices: A Single Center Experience
    Schwartz, Bryan G.
    Ludeman, Daniel J.
    Mayeda, Guy S.
    Kloner, Robert A.
    Economides, Christina
    Burstein, Steven
    CARDIOLOGY RESEARCH, 2012, 3 (02) : 54 - 66
  • [7] Single Center Experience of Long Term Outcomes of Severe Cardiogenic Shock Patients Needing IMPELLA 5.0 Placement
    Ibarra-Cortez, S. H.
    Araujo-Gutierrez, R.
    Cruz-Solbes, A. S.
    Bruckner, B.
    Estep, J. D.
    Suarez, E. E.
    Bhimaraj, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S432 - S432
  • [8] Cardiogenic Shock Spectrum: Outcomes Utilizing VA ECMO with or without Axillary Impella 5.0: Single Center Experience
    Kunavarapu, C.
    Kwan, M.
    Sterling, R.
    Tran, R.
    Rodriguez, S. M.
    Dellavolpe, J.
    Habib, P.
    Talathoti, J.
    Crist, B.
    Pearson, C.
    Ono, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S424 - S425
  • [9] Predictors of Mortality and Clinical Outcomes of Acute Severe Cardiogenic Shock Treated With the Impella® Device
    Rohm, Charlene
    Kadner, Marsha
    Leitson, Michael
    Gadidov, Bogdan
    Rudd, Jessica
    Ray, Herman
    Prasad, Rajnish
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B301 - B301
  • [10] Outcomes with Impella in Cardiogenic Shock
    Herve, Franck
    Tonleu, Azobou
    Lyle, Melissa
    Staloch, Dustin
    Sridharan, Lakshmi
    Bhatt, Kunal
    Morris, Alanna
    Burke, Michael
    Smith, Andrew
    Attia, Tamer
    Vega, John D.
    Daneshmand, Mani
    Jaber, Wissam
    Laskar, Sonjoy
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S155 - S156